Scabies Treatment, Permethrin, Oral Ivermectin and Household Follow-Up
A practical guide to coordinating treatment, caring for contacts and interpreting itching after treatment, using CDC and NHS guidance.
Treatment planning
Questions that distinguish scabies treatment options
This comparison describes CDC guidance for classic scabies. A clinician selects the product and regimen for age, pregnancy, weight, health history and local guidance.
Route and practical considerations
| Option | How it is used | What to confirm |
|---|---|---|
| Permethrin 5% cream | A scabicide applied to the prescribed skin areas | Full coverage, contact time and repeat application |
| Oral ivermectin | A clinician-selected tablet regimen | Weight, interactions, eligibility and repeat date |
| Crusted scabies care | Specialist plan using oral and topical medicines | Urgent assessment and infection-control arrangements |
| Household contact plan | Treat contacts on the agreed dates | Who needs assessment and a suitable preparation |
How are permethrin and oral ivermectin used for scabies?
Permethrin 5% cream and oral ivermectin are treatment options for scabies, selected according to the person and local guidance. CDC describes similar efficacy for classic scabies, while the practical requirements differ. Cream needs careful skin coverage, and tablets need a clinician to assess eligibility and the regimen.
In the US, CDC identifies permethrin 5% as FDA approved for scabies from two months of age and describes oral ivermectin use for scabies as off label. The oral ivermectin reference guide covers separate parasite indications and why the diagnosis must accompany a tablet-strength discussion.
How can you tell whether an itchy rash needs assessment?
Scabies commonly causes intense night-time itching and small raised lesions. Burrows may be visible, particularly around fingers or wrists, although a clinician considers the distribution and contact history together. Another household member itching can be relevant, but a photograph alone may not settle the diagnosis.
Tell the clinician when symptoms began, where they appeared and who has had close skin contact. CDC explains that symptoms may be delayed after a first infestation, while transmission can happen before symptoms. This is why a symptom-free contact may still need treatment.
What makes a cream application easy to get wrong?
Have the pharmacist explain the exact areas, amount, time on the skin and repeat date. Instructions can vary with age and local guidance. Ask specifically about fingers, nails, feet, skin folds and any area you cannot reach. If hands are washed during the treatment period, ask whether the product needs reapplying there.
Children, older adults and people with other skin conditions need an individually suitable plan. NHS guidance directs children under two years to a GP for assessment. Tell the treating professional about pregnancy or breastfeeding before selecting treatment.
For a product enquiry, GME lists Permethrin 5% w/w, 30g Cream. Confirm the manufacturer leaflet, quantity needed for the prescribed coverage and any repeat application.
What changes when the clinician selects tablets?
Give the prescriber your current weight, all medicines, pregnancy status and relevant health history. CDC states that oral ivermectin safety for scabies has not been established in pregnancy or in children weighing under 15 kg. It also identifies interaction considerations when choosing between treatments.
Food directions can depend on the indication. CDC scabies guidance describes taking oral ivermectin with food, while some other ivermectin labels describe an empty stomach. Have the clinician and pharmacist reconcile the directions for the treatment actually prescribed.
Who should be treated at the same time?
CDC prevention guidance recommends coordinated treatment of household members and close contacts. The NHS also advises treating sexual contacts from the relevant recent period. Tell the clinician about shared beds, caregiving and extended close contact so they can identify who needs a plan.
Write a household checklist with each person, their preparation, first treatment date and planned repeat date. Confirm that everyone has suitable instructions, especially children or anyone pregnant. Avoid sharing another person's prescription or applying an adult plan to an infant.
What should happen to clothes, towels and bedding?
CDC advises washing clothing and bedding used during the three days before treatment began, using hot washing and drying or dry cleaning. Seal items that cannot be washed in a closed bag for several days to a week. Follow the local instructions alongside the treatment timeline.
Choose clean clothes and bedding for after treatment and coordinate laundry with the household dates. Routine pesticide sprays or fogging are discouraged. If a care home or other group setting is involved, the responsible clinical or public-health team should direct infection control.
Does continued itching mean the treatment failed?
Itching can continue for several weeks because the skin is reacting to mite material even after mites are killed. CDC advises reassessment if itching continues more than two to four weeks after treatment or if new burrows or pimple-like lesions appear.
Record whether old lesions are settling, whether new ones appear and whether every planned application and contact treatment happened. The clinician can consider persistent inflammation, missed coverage, re-exposure or another diagnosis. Ask what symptom relief is appropriate while waiting for the skin to recover.
When do crusting or skin sores change the plan?
A widespread thick or crusted rash needs prompt assessment, particularly in an older or immunocompromised person. CDC describes crusted scabies as highly contagious and requiring combined oral and topical treatment with infection-control support. It may cause surprisingly little itching.
Seek prompt medical advice for sores, pus, increasing pain or signs of skin infection. If a prescription ointment is proposed, use the mupirocin skin guide to identify its role and exact directions. Treatment for a secondary infection needs to be considered alongside the scabies plan.
Export product support
Need product, pack, and documentation details?
Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.
Common questions
Can scabies affect someone with good hygiene?
Yes. It spreads through close contact and can affect anyone. Coordinating treatment and contacts is the useful next step.
Can I use a lice preparation for scabies?
Check the active ingredient, concentration, intended condition and instructions with a pharmacist. Different preparations need different coverage and contact times.
Should we wait for everyone to itch before treating contacts?
Contact treatment can be necessary before symptoms appear. Ask the clinician to identify contacts and coordinate their treatment dates.
What should I do if one household member missed the repeat treatment?
Contact the treating team for advice and give the actual treatment dates for everyone. They can assess whether the shared plan needs adjusting.
When can I return to school or work?
Follow local guidance and advice for your setting. NHS advice includes avoiding close contact for the first 24 hours after starting treatment, with specific return arrangements for younger children.
Can I catch human scabies from my pet?
CDC states that pets do not spread human scabies. An animal with mange needs veterinary care for its own condition.
Should I repeat treatment whenever I itch?
Use the prescribed repeat plan. Ongoing itching, new lesions and the contact timeline should be reviewed before adding applications or tablets.
What should I bring if symptoms persist?
Bring treatment names, dates, coverage instructions, contact treatment dates and photos showing new lesions. Mention any skin sores or crusting.
Important medical note
This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.